Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 373 results found since Jan 2013.
The Florence Statement on Triclosan and Triclocarban
Author Affiliations open
1Biodesign Center for Environmental Security, Arizona State University, Tempe, Arizona, USA
2Green Science Policy Institute, Berkeley, California, USA
3Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
4Environmental Working Group, Washington, District of Columbia, USA
5Department of Civil, Environmental, and Geo-Engineering, University of Minnesota, Minneapolis, Minnesota, USA
6Medical University of South Carolina, Department of Public Health Sciences, Charleston, South Carolina, USA
7Health Research Communicati...
Source: EHP Research - June 20, 2017 Category: Environmental Health Authors: Daniil Lyalko Tags: Brief Communication Source Type: research
Billionaire Koch brother donates $10M to Stanford children's hospital to back allergy research
Koch Industries executive David Koch and his wife have donated $10 million to advance allergy research at Stanford. The funding will allow researchers to grow the team at its new campus and run more clinical trials.
Source: bizjournals.com Health Care:Physician Practices headlines - June 17, 2017 Category: American Health Authors: Antoinette Siu Source Type: news
Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis
Publication date: Available online 13 June 2017 Source:The Lancet Haematology Author(s): Mary Eapen, Tao Wang, Paul A Veys, Jaap J Boelens, Andrew St Martin, Stephen Spellman, Carmem Sales Bonfim, Colleen Brady, Andrew J Cant, Jean-Hugues Dalle, Stella M Davies, John Freeman, Katherine C Hsu, Katharina Fleischhauer, Chantal Kenzey, Joanne Kurtzberg, Gerard Michel, Paul J Orchard, Annalisa Paviglianiti, Vanderson Rocha, Michael R Veneris, Fernanda Volt, Robert Wynn, Stephanie J Lee, Mary M Horowitz, Eliane Gluckman, Annalisa Ruggeri Background The standard for selecting unrelated umbilical cord blood units for transplantat...
Source: The Lancet Haematology - June 14, 2017 Category: Hematology Source Type: research
ERC Starting Grant for allergy research in the gut
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) The European Research Council (ERC) will be funding the ALLERGUT project at the Helmholtz Zentrum M ü nchen for the next five years with an ERC Starting Grant. Working in this framework, the researchers headed by Dr. Caspar Ohnmacht want to discover if and how bacteria in the intestines can assist or prevent the development of allergies. The total funding amounts to 1.5 million euros.
Source: EurekAlert! - Biology - June 2, 2017 Category: Biology Source Type: news
The Role and Treatment Implications of Peripheral and Central Processing of Pain, Pruritus, and Nausea in Heightened Somatic Awareness: A Review
This article reviews the acute neural transmission of pain, pruritus, and nausea symptoms, which can begin in the periphery and/or viscera. The subsequent multiple pathways in the central nervous system that become involved in the processing of these symptoms are also discussed. The authors describe human brain imaging studies that have revealed consistent cortical and subcortical networks activated by these symptoms, including sensory, limbic, and associative regions. In particular, the authors discuss information revealed by the studies regarding the primary somatosensory cortex, secondary somatosensory cortex, anterio...
Source: Innovations in Clinical Neuroscience - June 1, 2017 Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Neurologic Systems and Symptoms Neurology Pain Review central processing nausea pruritus Source Type: research
Correction
With regard to the article in the April 2017 issue entitled ‘‘Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173” (J Allergy Clin Immunol 2017;139:1396-9), the authors wish to amend the funding support section to state “A portion of this study was supported by grants from the Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry for Health and Welfare, Republic of Korea (HI12C0066; to J.-H.C.), and the Brain Research Program through th...
Source: Journal of Allergy and Clinical Immunology - June 1, 2017 Category: Allergy & Immunology Tags: Correction Source Type: research
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
This study is registered with ClinicalTrials.gov, number NCT01052480. Findings Between Jan 13, 2011, and March 2, 2015, 113 participants were screened for eligibility and 98 were randomly assigned from 20 out of 29 participating sites. Of the participants with confirmed influenza (by PCR), 28 (67%) of 42 in the plasma plus standard care group normalised their respiratory status by day 28 compared with 24 (53%) of 45 participants on standard care alone (p=0·069). The hazard ratio (HR) comparing plasma plus standard care with standard care alone was 1·71 (95% CI 0·96–3·06). Six participants died, one (2%) from the plas...
Source: The Lancet Respiratory Medicine - May 16, 2017 Category: Respiratory Medicine Source Type: research
Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial
Publication date: Available online 5 May 2017 Source:The Lancet Respiratory Medicine Author(s): Patricia van Velzen, Gerben ter Riet, Paul Bresser, Jeroen J Baars, Bob T J van den Berg, Jan W K van den Berg, Paul Brinkman, Jennece W F Dagelet, Johannes M A Daniels, Dewi R G L Groeneveld-Tjiong, René E Jonkers, Coen van Kan, Frans H Krouwels, Karin Pool, Arjan Rudolphus, Peter J Sterk, Jan M Prins Background Antibiotics do not reduce mortality or short-term treatment non-response in patients receiving treatment for acute exacerbations of COPD in an outpatient setting. However, the long-term effects of antibiotics are unkn...
Source: The Lancet Respiratory Medicine - May 6, 2017 Category: Respiratory Medicine Source Type: research
The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died.
What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news
Lyndra gets boost for drug delivery platform from U.S. allergy institute
Lyndra said today that it won a 5-year grant from the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health. The grant is slated to support the formulation and preclinical development of a once-weekly oral HIV treatment.
The Watertown, Mass.-based company makes use of a sustained-release technology developed by Robert Langer at the Massachusetts Institute of Technology. A star-shaped pill loaded with drugs remains in the gastric cavity after it’s been swallowed for a pre-determined length of time. After the drugs have been released, the pill splits into small pieces and saf...
Source: Mass Device - May 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Pharmaceuticals Research & Development lyndra Source Type: news
NIH funds 7 international Centers of Excellence for malaria research
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, today announced approximately $9 million in first-year funding, subject to availability, for seven malaria research centers around the world. The seven-year awards continue NIAID's 2010 program that created the International Centers of Excellence for Malaria Research (ICEMRs) in regions where malaria is endemic. The awards fund new and existing centers that work in 14 countries in Africa, Asia and Latin America.
Source: EurekAlert! - Medicine and Health - April 21, 2017 Category: Global & Universal Source Type: news
Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling study
Publication date: Available online 18 April 2017 Source:The Lancet HIV Author(s): Steven M Goodreau, Eli S Rosenberg, Samuel M Jenness, Nicole Luisi, Sarah E Stansfield, Gregorio A Millett, Patrick S Sullivan Background In the USA, men who have sex men (MSM) are at high risk for HIV, and black MSM have a substantially higher prevalence of infection than white MSM. We created a simulation model to assess the strength of existing hypotheses and data that account for these disparities. Methods We built a dynamic, stochastic, agent-based network model of black and white MSM aged 18–39 years in Atlanta, GA, USA, that incorpo...
Source: The Lancet HIV - April 19, 2017 Category: Infectious Diseases Source Type: research
NIH designates $42.7 million for food allergy research consortium
(NIH/National Institute of Allergy and Infectious Diseases) The National Institutes of Health intends to award $42.7 million over seven years to the Consortium of Food Allergy Research (CoFAR) so it may continue evaluating new approaches to treat food allergy. Established in 2005, the CoFAR has been continuously funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH. The first year of funding has been awarded, and awards will be made in subsequent years based on the availability of funds.
Source: EurekAlert! - Medicine and Health - March 29, 2017 Category: Global & Universal Source Type: news
